Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000950137-04-006817
Filing Date
2004-08-16
Accepted
2004-08-16 10:26:29
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c87506e10qsb.htm 10QSB 234661
2 THIRD AMENDMENT TO THE LICENSE AGREEMENT c87506exv10w3.htm EX-10.3 52317
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c87506exv31w1.htm EX-31.1 6376
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER c87506exv31w2.htm EX-31.2 6388
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c87506exv32w1.htm EX-32.1 2845
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER c87506exv32w2.htm EX-32.2 2851
  Complete submission text file 0000950137-04-006817.txt   307759
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-31812 | Film No.: 04976593
SIC: 2836 Biological Products, (No Diagnostic Substances)